← Back to Analyst Consensus 
BRTX Buy
BioRestorative Therapies, Inc.
Current Price —
Implied Upside —
Analysts 8
30-Day Momentum
▲ 0 upgrades / ▼ 1 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 10, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 6, 2026 | Maxim Group | downgrade | Buy → Hold | — | 42% |
| Aug 14, 2024 | Roth MKM | maintain | Buy → Buy | $18 | 52% |
| Jun 12, 2024 | Roth MKM | maintain | Buy → Buy | $15 | 52% |
| Aug 14, 2023 | Roth MKM | reiterate | Buy → Buy | $15 | 52% |
| Dec 7, 2022 | Roth Capital | initiate | — → Buy | $15 | 52% |
| Sep 28, 2022 | Maxim Group | initiate | — → Buy | $6 | 42% |
| Dec 1, 2021 | Roth Capital | initiate | — → Buy | $37 | 52% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days